Centor Score Strep Calculator
Estimate probability of group A streptococcal pharyngitis using modified Centor criteria. Enter values for instant results with step-by-step formulas.
Formula
Modified Centor Score = Tonsillar Exudates + Cervical Nodes + Fever + No Cough + Age Modifier
Each clinical criterion (tonsillar exudates, tender anterior cervical lymphadenopathy, fever > 38 C, absence of cough) scores 1 point. Age modifier: +1 for age 3-14, 0 for age 15-44, -1 for age 45+. Total range: 0 to 5.
Worked Examples
Example 1: Adolescent with Classic Strep Presentation
Problem: A 12-year-old presents with sore throat for 2 days, tonsillar exudates, tender anterior cervical nodes, fever of 39.2 C, and no cough.
Solution: Modified Centor (McIsaac) Score:\nTonsillar exudates: +1\nTender anterior cervical nodes: +1\nFever > 38 C: +1\nAbsence of cough: +1\nAge 3-14: +1\nTotal Score = 5\nProbability of GAS: 51 - 53%
Result: Score 5 | High probability (51-53%) | Perform RADT, consider empiric antibiotics
Example 2: Adult with Viral-Like Symptoms
Problem: A 50-year-old presents with sore throat, cough, runny nose, no fever, no tonsillar exudates, and no cervical lymphadenopathy.
Solution: Modified Centor (McIsaac) Score:\nTonsillar exudates: 0\nTender anterior cervical nodes: 0\nFever > 38 C: 0\nAbsence of cough: 0 (cough IS present)\nAge >= 45: -1\nTotal Score = 0 (minimum)\nProbability of GAS: 1 - 2.5%
Result: Score 0 | Very low probability (1-2.5%) | No testing or antibiotics needed
Frequently Asked Questions
What is the Centor score and what does it predict?
The Centor score is a clinical prediction rule developed by Dr. Robert Centor in 1981 to estimate the probability that a sore throat (pharyngitis) is caused by Group A Streptococcus (GAS) bacteria. The original Centor criteria include four elements: tonsillar exudates, tender anterior cervical lymphadenopathy, fever history, and absence of cough. Each positive finding adds one point, giving a score range of 0 to 4. The modified Centor score (also called the McIsaac score) adds an age modifier, giving a range of 0 to 5. Higher scores indicate a greater likelihood of streptococcal pharyngitis and help clinicians decide whether to test or treat empirically.
How does the modified Centor (McIsaac) score differ from the original?
The modified Centor score, developed by McIsaac and colleagues in 1998, improves upon the original by incorporating a patient age modifier to better account for the epidemiology of Group A Streptococcus across age groups. Children aged 3 to 14 receive an additional point because GAS pharyngitis is most prevalent in this age group, with peak incidence between ages 5 and 15. Adults aged 15 to 44 receive no age adjustment. Adults aged 45 and older have one point subtracted because GAS pharyngitis is significantly less common in older adults. This modification improves the specificity of the scoring system and reduces unnecessary antibiotic prescribing in older patients while maintaining sensitivity in children.
What is the probability of strep throat at each score level?
The probability of Group A Streptococcal pharyngitis increases significantly with each additional point on the modified Centor scale. At a score of 0 or negative, the probability is approximately 1 to 2.5 percent, essentially ruling out GAS. A score of 1 corresponds to roughly 5 to 10 percent probability. A score of 2 raises the probability to 11 to 17 percent. A score of 3 indicates a 28 to 35 percent probability. A score of 4 or 5 suggests a 51 to 53 percent probability, which is the highest predictive value of the tool. Even at the maximum score, nearly half of patients will not have GAS, which is why most guidelines still recommend confirmatory testing before prescribing antibiotics rather than treating empirically.
Why is the absence of cough included as a criterion in the Centor score?
The absence of cough is included because cough is a hallmark symptom of viral upper respiratory infections, which cause the vast majority of pharyngitis cases. When cough is present, it strongly suggests a viral etiology such as rhinovirus, adenovirus, influenza, or parainfluenza rather than Group A Streptococcus. GAS pharyngitis typically presents with acute onset of sore throat, odynophagia, fever, and cervical lymphadenopathy WITHOUT prominent cough, rhinorrhea, or other upper respiratory symptoms. The presence of cough reduces the probability of strep throat from approximately 15 percent in the general pharyngitis population to less than 5 percent in most studies. This makes cough absence one of the most useful differentiating features between bacterial and viral pharyngitis.
Should antibiotics be prescribed based solely on the Centor score?
Most current guidelines, including those from the Infectious Diseases Society of America (IDSA) and the American Academy of Family Physicians, recommend against prescribing antibiotics based solely on the Centor score without microbiological confirmation. The IDSA specifically recommends throat culture or rapid antigen detection testing (RADT) before initiating antibiotics, even for patients with high Centor scores. This is because even at a score of 4 or 5, roughly half of patients do not have GAS, and unnecessary antibiotics contribute to antimicrobial resistance, adverse drug reactions, and increased healthcare costs. However, some international guidelines, such as NICE in the UK, allow a more flexible approach with delayed prescriptions for moderate-risk patients to reduce unnecessary antibiotic use while providing a safety net.
Can the Centor score be used in children under 3 years of age?
The Centor score and modified Centor (McIsaac) score were not designed for and should not be used in children under 3 years of age. Group A Streptococcal pharyngitis is uncommon in this age group, and the clinical presentation differs significantly from older children and adults. Toddlers with GAS infection more often present with streptococcal nasopharyngitis (streptococcosis) characterized by fever, nasal discharge, and irritability rather than classic pharyngitis. The American Academy of Pediatrics (AAP) recommends against routine testing for GAS in children under 3 unless there are specific risk factors such as a sibling with confirmed strep throat. When GAS is suspected in this age group, direct throat culture rather than clinical prediction rules should guide management decisions.